Clinical Trials
11 trialsNCT05735717 2026-04-06
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT00280202 2025-10-24
Detection of Genetic Markers of Lung Cancer
University of Pittsburgh
Recruiting
NCT05013944 2024-01-30
AnovaOS Network Powered Patient Registry
Anova Enterprises, Inc
Recruiting
NCT05371873 2023-09-13
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer
First Affiliated Hospital of Zhejiang University
Unknown
NCT02403310 2022-10-03
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT05456048 2022-07-13
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Nanfang Hospital, Southern Medical University
Completed
NCT01242774 2020-12-19
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Novartis
Phase 1 Completed
NCT03998371 2019-06-26
Application of UCAD for Diagnosing Urothelial Carcinoma.
Changhai Hospital
Unknown
NCT01620853 2015-02-06
Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)
Applied Spectral Imaging Ltd.
Completed
NCT01264744 2010-12-23
Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)
Applied Spectral Imaging Ltd.
Completed
NCT00461929 2009-02-13
GIST
University Health Network, Toronto
Phase 4 Terminated